Same Indication

Ipilimumab vs Ramipril

Ipilimumab vs Ramipril: Overview

This comparison examines the pharmacological differences between Ipilimumab and Ramipril.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Ramipril: Prodrug converted to ramiprilat; ACE inhibitor.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Ramipril — 13-17 hours.

Chemical Properties

Molecular Formula: Ramipril — C23H32N2O5.

Molecular Weight: Ramipril — 416.5120 g/mol.

Type: Ipilimumab — Antibody; Ramipril — Small molecule.